• Profile
Close

Urinary angiostatin: A novel biomarker of kidney disease associated with disease severity and progression

BMC Nephrology Apr 07, 2019

Xia YY, et al. - Researchers assessed the utility of urinary angiostatin levels for the evaluation of severity and progression of IgA nephropathy (IgAN). A significantly higher level of urinary angiostatin levels was reported in IgAN cases when compared to healthy controls (HC) subjects whereas it was lower as compared to disease controls (DC) patients. Findings revealed a positive association of concentrations of angiostatin in urine normalized to urinary creatinine (angiostatin/Cr), with proteinuria level. A gradual increase in urinary angiostatin/Cr levels was seen with advancing chronic kidney disease (CKD) stage. Following follow-up, patients with higher levels of urinary angiostatin had significantly worse renal survival. Based on the findings, they concluded that urinary angiostatin could have utility as a novel noninvasive biomarker to assess disease severity and progression of IgAN.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay